Use of medroxyprogesterone acetate in the treatment of Müllerian adenosarcoma: a case report

Hines BJ, Brian J. Hines, Robert F. Porges, Porges RF, Kush Mittal, Mittal K, Franco M. Muggia, John P. Curtin
Gynecologic Oncology · 2002 · vol. 85(1) , pp. 192–195 · doi:10.1006/gyno.2002.6585 · PMID:11925144 · W2121093992
Case report OA: closed CC0 ⤵ 4 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-08 ⓘ

This case report details the treatment of a patient with Müllerian adenosarcoma using medroxyprogesterone acetate.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

BACKGROUND: Müllerianadenosarcoma is a rare pelvic malignancy that most commonly arises from the endometrium. These tumors are relatively insensitive to chemotherapy and radiation and are primarily treated by surgical resection. We report a case of müllerian adenosarcoma arising outside of the uterus from a background of endometriosis treated with a combination of surgical resection and medroxyprogesterone acetate. CASE: A 43-year-old woman with a history of endometriosis was diagnosed with advanced extrauterine müllerian adenosarcoma. After suboptimal tumor dubulking surgery she was treated with medroxyprogesterone acetate. Ten months postoperatively she remains without evidence of disease. CONCLUSION: Medroxyprogesterone acetate may be a useful drug in the treatment of advanced müllerian adenosarcoma.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Adenosarcoma Antineoplastic Agents, Hormonal Genital Neoplasms, Female Medroxyprogesterone Acetate Mixed Tumor, Mullerian Adenosarcoma Adenosarcoma Adenosarcoma Adult Adult Antineoplastic Agents, Hormonal Antineoplastic Agents, Hormonal Combined Modality Therapy Combined Modality Therapy Endometriosis Endometriosis Endometriosis Female Female Genital Neoplasms, Female

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (3)

Cited by (4)

References (9)

Cited by (4)

Source provenance

europepmc
last seen: 2026-11-02T06:09:15.937778+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-10-08T21:00:24.492322+00:00
unpaywall
last seen: 2026-11-02T06:26:32.194460+00:00
License: CC0 · commercial use OK